Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease

Abstract

Individualized autoimmune neurologic diagnoses may be accelerated using protein arrays. They are optimal for detection of intracellular antigen-reactive antibodies, though certain cell surface-directed antibodies (neurexin-3α and SEZ6L2) may also be detected.